Thus, further characterization of NF‐κB pathway components, their activation, and regulation in Behçet syndrome and related conditions may link clinical features to altered NF‐κB activation patterns and aid in the development of novel therapies (Figure 2). The gene discussed is NFKB1; the disease is Behcet disease.